TENX

Tenax Therapeutics, Inc. [TENX] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

TENX Stock Summary

Top 10 Correlated ETFs

TENX


Top 10 Correlated Stocks

TENX


In the News

08:53 04 Mar 2024 TENX

Why Is Tenax Therapeutics (TENX) Stock Down 64% Today?

Tenax Therapeutics (NASDAQ: TENX ) stock is falling hard on Thursday after the pharmaceutical company announced details for a public offering of its shares. That public offering has Tenax Therapeutics selling 1.6 million units.

10:01 04 Mar 2024 TENX

Biotech stock Tenax Therapeutics more than doubled on Tuesday

Tenax Therapeutic Inc (NASDAQ: TENX) opened nearly 150% up this morning after receiving approval for a patent application. Tenax Therapeutics stock rallies ahead of earnings The U.S. Patent and Trademark Office accepted its patent application for levosimendan – its candidate treatment for pulmonary hypertension in patients of heart failure.

03:22 04 Mar 2024 TENX

Why Is Tenax Therapeutics (TENX) Stock Up 300% Today?

Shares of pharmaceutical specialist Tenax Therapeutics (NASDAD: TENX ) are skyrocketing on Monday amid encouraging regulatory news. More specifically, with a focus on addressing cardiovascular and pulmonary diseases with high unmet medical need, Tenax has received clearance for its investigational new drug (IND) application for its pulmonary hypertension therapeutic.

12:27 04 Mar 2024 TENX

Tenax Therapeutics shares soar after FDA clears IND for hypertension candidate NX-103

Shares of Tenax Therapeutics surged over 300% after it announced the US Food and Drug Administration has reviewed and cleared its Investigational New Drug (IND) application for its hypertension candidate, TNX-103. The specialty pharmaceutical company said the  FDA's enables it to proceed with the first of two Phase 3 studies for TNX-103 (oral Levosimendan) for the treatment of pulmonary hypertension with heart failure with preserved ejection fraction (PH-HFpEF).

07:20 04 Mar 2024 TENX

7 F-Rated Biotech Stocks You Shouldn't Touch With a 10-Foot Pole

Investing in biotech stocks can be challenging. The rewards can be great when your company hits on a popular drug, treatment or product.

11:16 04 Mar 2024 TENX

5 Hot Penny Stocks To Watch With Big News This Week

Whether you're trading penny stocks or higher-priced company shares, everyone wants to gain an edge. In the stock market today, there are plenty of catalysts to consider.

06:00 04 Mar 2024 TENX

Penny Stocks Trading: Tips for Setting Realistic Investing Goals

Setting penny stocks investing goals? Use these 3 top tips The post Penny Stocks Trading: Tips for Setting Realistic Investing Goals  appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

06:00 04 Mar 2024 TENX

Analyzing Penny Stocks After a Market Crash, 3 Tips

Use these tips for analyzing penny stocks after a market crash The post Analyzing Penny Stocks After a Market Crash, 3 Tips appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

07:52 04 Mar 2024 TENX

Why Is Tenax Therapeutics (TENX) Stock Up 149% Today?

Tenax Therapeutics (NASDAQ: TENX ) stock is rocketing higher on Thursday after getting an update on one of its patents. That includes a Notice of Allowance from the USPTO.

11:01 04 Mar 2024 TENX

Why Is Tenax Therapeutics (TENX) Stock On the Move Today?

Tenax Therapeutics (NASDAQ: TENX ) stock is on the move Wednesday after the company announced plans for a reverse stock split. At 5:00 p.m.

TENX Financial details

Company Rating
Neutral
Market Cap
8.85M
Income
-9.98M
Revenue
0
Book val./share
0.47
Cash/share
0.47
Dividend
-
Dividend %
-
Employees
7
Optionable
No
Shortable
Yes
Earnings
28 Mar 2024
P/E
-37.46
Forward P/E
-17.24
PEG
4.04
P/S
-
P/B
33.11
P/C
10.64
P/FCF
-0.66
Quick Ratio
18.5
Current Ratio
19.73
Debt / Equity
0.02
LT Debt / Equity
-
-
-
EPS (TTM)
-2.33
EPS next Y
-0.29
EPS next Q
1.58
EPS this Y
-76.39%
EPS next Y
-87.78%
EPS next 5Y
-87.78%
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
65.2%
-
-
-
-
SMA20
-61.57%
SMA50
-80.67%
SMA100
-81.51%
Inst Own
0%
Inst Trans
0%
ROA
-84%
ROE
-99%
ROC
-1.3%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
1.77M
Shs Float
1.69M
-
-
-
-
Target Price
-
52W Range
3.77-64.4
52W High
-92.19%
52W Low
+66.67%
RSI
39.37
Rel Volume
1.65
Avg Volume
325.74K
Volume
537.44K
Perf Week
14.94%
Perf Month
-46.92%
Perf Quarter
-79.37%
Perf Half Y
-81.88%
-
-
-
-
Beta
2.452
-
-
Volatility
0.36%, 3.44%
Prev Close
8.93%
Price
5
Change
18.76%

TENX Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric History 2018-12-312019-12-312020-12-312021-12-31 2022-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
00000
Net income per share
-86.07-27.1-19.05-31.81-7.51
Operating cash flow per share
-70.29-24.39-17.89-10.55-8.16
Free cash flow per share
-70.39-24.4-17.9-10.56-8.17
Cash per share
164.417.4312.955.431.44
Book value per share
150.4612.188.924.131.01
Tangible book value per share
150.4612.188.924.131.01
Share holders equity per share
150.4612.188.924.131.01
Interest debt per share
00.550.590.280.55
Market cap
151.47M698.85M1.54B1.71B261.3M
Enterprise value
139.1M694.11M1.54B1.71B259.99M
P/E ratio
-22.49-83.25-156.26-52.31-23.66
Price to sales ratio
00000
POCF ratio
-27.54-92.49-166.34-157.7-21.75
PFCF ratio
-27.5-92.44-166.28-157.62-21.75
P/B Ratio
12.87185.25333.46403.34175.05
PTB ratio
12.87185.25333.46403.34175.05
EV to sales
00000
Enterprise value over EBITDA
-20.21-82.16-157.83-52.73-23.79
EV to operating cash flow
-25.29-91.86-165.7-157.21-21.64
EV to free cash flow
-25.26-91.82-165.64-157.14-21.64
Earnings yield
-0.04-0.01-0.01-0.02-0.04
Free cash flow yield
-0.04-0.01-0.01-0.01-0.05
Debt to equity
00.050.070.070.54
Debt to assets
00.030.040.050.24
Net debt to EBITDA
1.80.560.610.160.12
Current ratio
8.512.443.213.641.74
Interest coverage
00-6.07K-34.49K-2.49K
Income quality
0.390.90.940.331.09
Dividend Yield
0.050000
Payout ratio
-1.090000
Sales general and administrative to revenue
00000
Research and developement to revenue
00000
Intangibles to total assets
00000
Capex to operating cash flow
00000
Capex to revenue
00000
Capex to depreciation
-0.84-0.03-0.03-0.05-0.02
Stock based compensation to revenue
00000
Graham number
539.7886.1761.8454.3413.09
ROIC
-0.58-2.08-1.98-6.83-4.45
Return on tangible assets
-0.5-1.32-1.44-5.46-3.24
Graham Net
144.389.068.623.730.14
Working capital
11.75M3.65M4.68M4.13M1.36M
Tangible asset value
11.77M3.77M4.63M4.24M1.49M
Net current asset value
11.75M3.59M4.55M3.94M1.3M
Invested capital
00.050.070.070.54
Average receivables
25.09K0000
Average payables
680.84K1.21M1.21M808.75K654.03K
Average inventory
00000
Days sales outstanding
00000
Days payables outstanding
05.65K2.41K2.88K1.44K
Days of inventory on hand
00000
Receivables turnover
00000
Payables turnover
00.060.150.130.25
Inventory turnover
00000
ROE
-0.57-2.23-2.13-7.71-7.4
Capex per share
-0.1-0.01-0.01-0.010

Quarterly Fundamentals Overview

Last date of statement is 2023-09-30 for Q3

Metric History 2022-09-302022-12-312023-03-312023-06-30 2023-09-30
2.02K2.02K2.02K2.02K2.02K
Revenue per share
00000
Net income per share
-6.65-1.73-0.47-0.05-0.08
Operating cash flow per share
-2.53-1.57-0.19-0.04-0.09
Free cash flow per share
-2.53-1.57-0.19-0.04-0.09
Cash per share
2.891.441.550.610.47
Book value per share
31.011.540.60.47
Tangible book value per share
31.011.540.60.47
Share holders equity per share
31.011.540.60.47
Interest debt per share
0.160.550.060.020.01
Market cap
358.09M261.3M345.99M530.79M570.79M
Enterprise value
354.49M259.99M332.09M517.74M559.82M
P/E ratio
-10.23-25.67-19.87-119.94-72.36
Price to sales ratio
00000
POCF ratio
-107.51-112.97-200.59-575.09-274.27
PFCF ratio
-107.51-112.85-200.73-575.09-274.27
P/B Ratio
90.57175.0524.2340.1550.57
PTB ratio
90.57175.0524.2340.1550.57
EV to sales
00000
Enterprise value over EBITDA
-122.76-103.19-237.46-472.3-284.8
EV to operating cash flow
-106.43-112.4-192.53-560.96-269
EV to free cash flow
-106.43-112.29-192.67-560.96-269
Earnings yield
-0.02-0.01-0.0100
Free cash flow yield
-0.01-0.01000
Debt to equity
0.050.540.040.030.02
Debt to assets
0.040.240.030.020.01
Net debt to EBITDA
1.240.529.9411.95.58
Current ratio
6.541.7415.5217.0419.73
Interest coverage
7.84K-4.8K209.45135.45396.74
Income quality
1.140.911.230.831.06
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
00000
Research and developement to revenue
00000
Intangibles to total assets
00000
Capex to operating cash flow
00000
Capex to revenue
00000
Capex to depreciation
0-0.081.3900
Stock based compensation to revenue
00000
Graham number
21.196.284.020.820.94
ROIC
2-7.860.320.09-0.2
Return on tangible assets
-1.85-0.75-0.29-0.08-0.17
Graham Net
2.290.141.440.570.44
Working capital
3.82M1.36M14.28M13.21M11.28M
Tangible asset value
3.95M1.49M14.28M13.22M11.29M
Net current asset value
3.73M1.3M14.27M13.21M11.28M
Invested capital
0.050.540.040.030.02
Average receivables
00000
Average payables
592.4K356.92K310.23K189.25K170.62K
Average inventory
00000
Days sales outstanding
00000
Days payables outstanding
837.751.38K17.3K18.58K12.13K
Days of inventory on hand
00000
Receivables turnover
00000
Payables turnover
0.110.070.0100.01
Inventory turnover
00000
ROE
-2.21-1.7-0.3-0.08-0.17
Capex per share
00000

TENX Frequently Asked Questions

What is Tenax Therapeutics, Inc. stock symbol ?

Tenax Therapeutics, Inc. is a US stock , located in Morrisville of Nc and trading under the symbol TENX

What is Tenax Therapeutics, Inc. stock quote today ?

Tenax Therapeutics, Inc. stock price is $5 today.

Is Tenax Therapeutics, Inc. stock public?

Yes, Tenax Therapeutics, Inc. is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Top Correlated Stocks
Similar Market Cap